Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart D Rosen

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Future Healthcare Journal|July 1, 2026
National study of medical education, ethical attitudes and curricular exposure to voluntary assisted dying by VOICE (Views Of Incoming Clinicians on End-of-life care)Hamaad Ahmad Khan, Karanjot Chhatwal, Michael Bryan, et al.
The Lancet. Oncology|March 8, 2013
Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)Ruth E Langley, Fay H Cafferty, Abdulla A Alhasso, et al.
Contemporary Clinical Trials|March 18, 2023
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected dataArchie Macnair, Matthew Nankivell, Macey L Murray, et al.
European Journal of Heart Failure|March 19, 2016
Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trialHitesh C Patel, Stuart D Rosen, Carl Hayward, et al.
BJU International|October 19, 2016
Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancerDuncan C Gilbert, Trinh Duong, Howard G Kynaston, et al.
Breast Cancer Research and Treatment|April 5, 2021
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancerNicolò Matteo Luca Battisti, Maria Sol Andres, Karla A Lee, et al.
European Journal of Heart Failure|June 27, 2023
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaireMarkus S Anker, Sophia K Potthoff, Alessia Lena, et al.
European Journal of Heart Failure|December 28, 2017
Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure AssociationWolfram Doehner, Dilek Ural, Karl Georg Haeusler, et al.
Circulation|March 30, 2017
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic DysfunctionBrian P Halliday, Ankur Gulati, Aamir Ali, et al.
Lancet (London, England)|November 16, 2018
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialBrian P Halliday, Rebecca Wassall, Amrit S Lota, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Future Healthcare Journal|July 1, 2026
National study of medical education, ethical attitudes and curricular exposure to voluntary assisted dying by VOICE (Views Of Incoming Clinicians on End-of-life care)Hamaad Ahmad Khan, Karanjot Chhatwal, Michael Bryan, et al.
The Lancet. Oncology|March 8, 2013
Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)Ruth E Langley, Fay H Cafferty, Abdulla A Alhasso, et al.
Contemporary Clinical Trials|March 18, 2023
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected dataArchie Macnair, Matthew Nankivell, Macey L Murray, et al.
European Journal of Heart Failure|March 19, 2016
Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trialHitesh C Patel, Stuart D Rosen, Carl Hayward, et al.
BJU International|October 19, 2016
Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancerDuncan C Gilbert, Trinh Duong, Howard G Kynaston, et al.
Breast Cancer Research and Treatment|April 5, 2021
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancerNicolò Matteo Luca Battisti, Maria Sol Andres, Karla A Lee, et al.
European Journal of Heart Failure|June 27, 2023
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaireMarkus S Anker, Sophia K Potthoff, Alessia Lena, et al.
European Journal of Heart Failure|December 28, 2017
Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure AssociationWolfram Doehner, Dilek Ural, Karl Georg Haeusler, et al.
Circulation|March 30, 2017
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic DysfunctionBrian P Halliday, Ankur Gulati, Aamir Ali, et al.
Lancet (London, England)|November 16, 2018
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialBrian P Halliday, Rebecca Wassall, Amrit S Lota, et al.
Pageof 8